Hyphens Pharma to launch Maruho’s shingles drug in ASEAN

It will commercialise Amenalief® Tab 200mg in 10 ASEAN countries.

Japan-based pharma company Maruho has granted Hyphens Pharma the exclusive rights to register and commercialise shingles treatment, Amenalief® Tab 200mg, in 10 ASEAN countries.

The drug received approval and was launched in Japan in 2017.

In Singapore, more than 90% of adults over 50 carry Varicella-Zoster Virus type 2 (VZV2), putting older individuals at a higher risk of developing shingles.

Hyphens Pharma said Maruho's medication "has a novel mechanism of action that inhibits the proliferation of VZV by inhibiting the activity of the helicase-primase complex, which is essential for viral DNA replication."

"Amenalief® has proven to be effective against VZV when administered once a day for seven days, versus standard therapies that require either three or five times dosing per day. Unlike other oral therapies, Amenalief® does not require any dosage adjustment in patients with renal impairment, a common concern in older patients," Hyphens Pharma said in a bourse filing.

Reaching the people who run Asia's businesses is harder than it used to be.

Inboxes are crowded. Attention is short. The executives you most want to reach — the founders, CFOs, and operators who actually move budgets — are the hardest to find through the usual channels. If you're building a company, a category, or a reputation, you already know this.

We've spent twenty years building the room they read. Singapore Business Review is where senior decision makers in Singapore and across Southeast Asia come for business coverage they can't get elsewhere — in print, online, and in person at the summits and roundtables we host across seven markets.

If you have something these readers should know about — a point of view worth publishing, a product worth their attention, an event worth their time — we'd like to hear what you're trying to do.

Book a meeting

| Or download the media kit (PDF)

240,000 senior readers quarterly in print Top 1,700 Singapore companies reached

7 markets across Southeast Asia